SCHEMBL28895412

SCHEMBL28895412

O=C(NNC1CC1)Nc1ccc(O)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.54
RAB9A P51151 4/20 0.50
S1PR1 P21453 1/20 0.47
PDK1 Q15118 1/20 0.46
PDK2 Q15119 1/20 0.46
PDK3 Q15120 1/20 0.46
PDK4 Q16654 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
MAPK1 P28482 2/20 0.42
NPC1 O15118 3/20 0.41
ALDH1A1 P00352 1/20 0.41
CXCR2 P25025 1/20 0.41
USP30 Q70CQ3 1/20 0.41
UBE2M P61081 1/20 0.41
DCUN1D1 Q96GG9 1/20 0.41
CAMK2A Q9UQM7 1/20 0.40
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29419622 0.86 HTT (0.71) HTTRAB9AS1PR1PDK1PDK2
SCHEMBL1322743 0.86 HTT (0.71) HTTRAB9AS1PR1PDK1PDK2
SCHEMBL21750908 0.81 RAB9A (0.76) HTTRAB9AS1PR1NPC1ALDH1A1
SCHEMBL21750902 0.81 RAB9A (0.72) HTTRAB9AS1PR1NPC1CXCR2
SCHEMBL21750960 0.79 RAB9A (0.74) HTTRAB9AS1PR1MAPK1NPC1
SCHEMBL3717777 0.77 PDK1 (0.55) HTTRAB9AS1PR1PDK1PDK2
SCHEMBL24906148 0.76 ALDH1A1 (0.57) HTTRAB9AS1PR1PDK1PDK2
SCHEMBL29264920 0.75 S1PR1 (0.48) HTTRAB9AS1PR1PDK1PDK2
SCHEMBL21750979 0.75 MAOA (0.61) HTTRAB9ATRPV1MAPK1NPC1
SCHEMBL29757943 0.75 MAOA (0.61) HTTRAB9ATRPV1MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107305202-B HPLC method for analyzing impurities of levovatinib mesylate and preparation thereof and application of impurities as reference standard 北京睿创康泰医药研究院有限公司 2020-04-17 CN claimed
CN-107305202-B HPLC method for analyzing impurities of levovatinib mesylate and preparation thereof and application of impurities as reference standard 北京睿创康泰医药研究院有限公司 2020-04-17 CN disclosed